Centrum Medyczne ENEL-MED Valuation

Q: What is the Fair Price of E19 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

E19 (€4.4) is trading below our estimate of [[fair value]] (€13.34)

Is E19 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of E19 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: E19 (€4.4) is trading below our estimate of fair value (€13.34)

Significantly Below Fair Value: E19 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for E19?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for E19. This is calculated by dividing E19's market cap by their current preferred multiple.
What is E19's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	zł565.61m

E19 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.2x
Enterprise Value/EBITDA	47.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does E19's PE Ratio compare to its peers?

The above table shows the PE ratio for E19 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	17.3x
LIK LIMES Schlosskliniken	25.1x	n/a	€107.3m
M12 M1 Kliniken	18.5x	17.5%	€310.8m
JTH Gesundheitswelt Chiemgau	7x	n/a	€24.6m
RHK RHÖN-KLINIKUM	18.4x	5.1%	€856.8m
E19 Centrum Medyczne ENEL-MED	81x	n/a	€565.6m

Price-To-Earnings vs Peers: E19 is expensive based on its Price-To-Earnings Ratio (81x) compared to the peer average (17.3x).

Price to Earnings Ratio vs Industry

How does E19's PE Ratio compare vs other companies in the European Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: E19 is expensive based on its Price-To-Earnings Ratio (81x) compared to the European Healthcare industry average (18.9x).

Price to Earnings Ratio vs Fair Ratio

What is E19's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

E19 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	81x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate E19's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.